Package 63323-417-10

Brand: cisatracurium

Generic: cisatracurium besylate
NDC Package

Package Facts

Identity

Package NDC 63323-417-10
Digits Only 6332341710
Product NDC 63323-417
Product ID 63323-417_0431da49-a804-457c-a823-66d8862db3f2
Description

10 VIAL in 1 CARTON (63323-417-10) / 10 mL in 1 VIAL (63323-417-01)

Marketing

Marketing Status
Marketed Since 2015-02-26
Brand cisatracurium
Generic cisatracurium besylate
Sample Package No

Linked Drug Pages (1)

Cisatracurium ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "0431da49-a804-457c-a823-66d8862db3f2", "openfda": {"upc": ["0363323418014", "0363323416010", "0363323417017"], "unii": ["80YS8O1MBS"], "rxcui": ["199211", "199212", "1730194"], "spl_set_id": ["f78a07e2-0d3b-4460-b29e-8c10c90afbda"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL in 1 CARTON (63323-417-10)  / 10 mL in 1 VIAL (63323-417-01)", "package_ndc": "63323-417-10", "marketing_start_date": "20150226"}], "brand_name": "Cisatracurium", "product_id": "63323-417_0431da49-a804-457c-a823-66d8862db3f2", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Neuromuscular Nondepolarizing Blockade [PE]", "Nondepolarizing Neuromuscular Blocker [EPC]"], "product_ndc": "63323-417", "generic_name": "CISATRACURIUM BESYLATE", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cisatracurium", "active_ingredients": [{"name": "CISATRACURIUM BESYLATE", "strength": "2 mg/mL"}], "application_number": "ANDA203183", "marketing_category": "ANDA", "marketing_start_date": "20150226", "listing_expiration_date": "20261231"}